Study to Evaluate Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years and Older
Clinical trial NCT06727058 · COMPLETED
Trial details
- NCT number
- NCT06727058
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-09
- Primary completion
- 2026-03-24
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.